Innovent Reports Results of Tyvyt + Byvasda (biosimilar- bevacizumab) in P-lll ORIENT-32 Study as 1L Treatment for HCC
November 23, 2020
Innovent Report Results of Dual Regimen in P-III ORIENT-32 Study as 1L Therapy for Advanced HCC
September 28, 2020
Lilly and Innovent Report the Global Expansion of their Alliance for Tyvyt (sintilimab)
August 18, 2020
Innovent and Eli Lilly Report sNDA Acceptance of Tyvyt (sintilimab) Combination Regimen as 1L Therapy in Squamous Non-Small Cell L...
August 12, 2020
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.